Clinical trial
Safety and Efficacy of SPARC1203 in Allergic Rhinitis
NCT01614691 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of SPARC1203 in Allergic Rhinitis
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- March 31, 2013
- Enrollment
- 159 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis